Cost-effectiveness of posaconazole tablets versus fluconazole as prophylaxis for invasive fungal diseases in patients with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Santiago Grau, Rafael Cámara, Manuel Jurado, Jaime Sanz, Belén Aragón, Irmina Gozalbo
Year of publication: |
May 2018
|
---|---|
Authors: | Grau, Santiago ; Cámara, Rafael ; Jurado, Manuel ; Sanz, Jaime ; Aragón, Belén ; Gozalbo, Irmina |
Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 19.2018, 4, p. 627-636
|
Subject: | Posaconazole | Invasive fungal disease | Invasive fungal infection | Prophylaxis | Graft-versus-host disease | Cost-effectiveness | Infektionskrankheit | Infectious disease | Krankheit | Disease | Kosten-Wirksamkeits-Analyse | Cost-effectiveness analysis | Gesundheitsvorsorge | Preventive care |
Saved in:
Online Resource
Saved in favorites
Similar items by subject
-
Bennett, Hayley, (2017)
-
Schmidt, Ralph, (2017)
-
Cost-effectiveness and estimated health benefits of treating patients with vitamin D in pre-dialysis
Snyder, Sophie, (2020)
- More ...